Management of liver metastases from uveal melanoma
British Journal of Surgery · 01.08.2025 · 112 (8)
DOI: 10.1093/bjs/znaf130 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift British Journal of Surgery, online erschienen am 05.08.2025. Verfasst von Anne Huibers und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Liver Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Uveal melanoma is the most common primary intraocular malignancy in adults, with distinct genetic and clinical characteristics compared with cutaneous melanoma. Despite improvements in the treatment of the primary tumour, nearly half of the patients will develop distant metastases, most commonly in the liver. Once metastases are detected, the median overall survival is approximately 1 year, with a 2-year survival rate of only 8%. Systemic treatment, including chemotherapy, immunotherapy, and targeted therapy, has historically shown limited efficacy. The first (and so far only) systemic treatment to demonstrate an improvement in overall survival is tebentafusp, which is now approved for treatment of patients with metastatic or unresectable uveal melanoma and an HLA-A*02:01 genotype. Liver-directed therapies include surgical resection, radioembolization, chemoembolization, immune-embolization, isolated hepatic perfusion, and percutaneous hepatic perfusion. This review discusses the clinical background of uveal melanoma and liver metastasis, the efficacy of systemic and locoregional treatment options, and the promising development of combining locoregional liver-directed treatment with systemic treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Surgery, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Surgery, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Radiology, Sahlgrenska University Hospital, Gothenburg, Sweden.
- Department of Radiology, Leiden University Medical Centre, Leiden, The Netherlands.
- Department of Oncology, Institute of Clinical Sciences, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Oncology, Sahlgrenska University Hospital, Gothenburg, Sweden.
ORCID-Profile: Mark Burgmans, Roger Olofsson Bagge
Zitieren
APA
Huibers, A., Wong, A., Burgmans, M., Ny, L., Stålhammar, G., Kapiteijn, E., Zager, J. S., & Olofsson Bagge, R. (2025). Management of liver metastases from uveal melanoma. British Journal of Surgery, 112(8). https://doi.org/10.1093/bjs/znaf130
Vancouver
Huibers A, Wong A, Burgmans M, Ny L, Stålhammar G, Kapiteijn E, et al. Management of liver metastases from uveal melanoma. British Journal of Surgery. 2025;112(8). doi:10.1093/bjs/znaf130
BibTeX
@article{Huibers2025,
author = {Huibers, Anne and Wong, Andrew and Burgmans, Mark and Ny, Lars and Stålhammar, Gustav and Kapiteijn, Ellen and Zager, Jonathan S and Olofsson Bagge, Roger},
title = {Management of liver metastases from uveal melanoma},
journal = {British Journal of Surgery},
year = {2025},
volume = {112},
number = {8},
doi = {10.1093/bjs/znaf130}
}
EUVIMED